Loading clinical trials...
Loading clinical trials...
Allogeneic Bone Marrow Transplantation for Hematologic Malignancies: A Treatment Approach Based on Risk of Relapse and Toxicity
Conditions
Interventions
busulfan
Cyclophosphamide
+2 more
Locations
1
United States
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
Tampa, Florida, United States
Start Date
March 1, 1993
Primary Completion Date
July 1, 2007
Completion Date
July 1, 2007
Last Updated
December 10, 2020
NCT06735690
NCT00131014
NCT05564390
NCT06074666
NCT03050268
NCT07320235
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions